Table 1.

TESTEX score.

Study	1	2	3	4	5	6	7	8	9	10	11	12	Testex
	Eligibility	Randomization	Allocation	Groups Similar at Baseline	Assessor Blinding	Outcome Measures	Intention-to-Treat	Between groups Statistical Comparison	Point Measures and Measures of Variability	Activity Monitoring in Control Group	Exercise Intensity Remained Constant	Exercise Volume and Energy Expenditure
Avila et al., 2018 [19]	1	1	0	1	0	3	1	2	0	0	1	1	11
Avila et al., 2019 [20]	1	1	0	1	0	2	0	2	0	0	1	1	9
Batalik et al., 2021 [21]	1	1	1	1	0	3	0	1	0	0	1	1	10
Batalik et al., 2021a [22]	1	1	0	1	0	2	0	2	1	0	1	1	10
Batalik et al., 2020 [7]	1	1	1	1	0	3	0	2	0	1	1	1	12
Bravo-Escobar et al., 2021 [23]	1	0	0	0	0	0	0	2	0	0	1	1	5
Bravo-Escobar et al., 2017 [24]	1	1	0	0	0	1	0	2	0	0	1	1	7
Dale et al., 2015 [25]	1	1	1	0	0	3	1	2	0	0	0	1	10
De Lima et al., 2022 [26]	1	1	1	0	1	3	1	2	0	0	1	1	12
Dorje et al., 2019 [27]	1	1	1	1	1	3	1	2	1	0	0	0	12
Fang et al., 2019 [28]	1	0	0	1	0	0	0	2	0	0	0	0	4
Ghorbani et al., 2021 [29]	1	1	0	1	0	2	0	1	0	1	0	0	7
He et al., 2020 [30]	1	1	1	1	1	2	0	2	0	0	1	1	11
Hong et al., 2020 [31]	1	1	1	1	0	1	1	2	0	0	0	0	8
Kraal et al., 2017 [32]	1	1	1	1	0	3	1	2	0	1	1	1	13
Kraal et al., 2014 [33]	1	0	1	0	0	3	0	2	1	1	1	1	11
Lee et al., 2013 [34]	1	0	0	1	0	1	0	2	0	0	1	1	7
Lee et al., 2013a [35]	1	0	0	0	0	0	0	2	0	0	1	1	5
Maddison et al., 2015 [36]	1	1	1	1	1	3	1	2	0	0	1	0	12
Maddison et al., 2019 [37]	1	1	0	1	1	3	1	2	0	0	1	1	12
Reid et al., 2011 [38]	1	1	1	1	1	2	0	2	0	0	0	0	9
Shi et al., 2022 [39]	1	1	0	1	0	2	0	2	0	1	0	0	8
Skobel et al., 2017 [40]	1	1	0	0	0	3	0	2	0	0	1	1	9
Snoek et al., 2021 [41]	1	1	0	1	1	2	0	2	0	0	0	0	8
Snoek et al., 2021a [42]	1	1	0	1	0	3	1	2	0	0	1	1	11
Song et al., 2020 [43]	1	1	1	1	0	3	0	2	0	0	1	1	11
Su and Yu, 2021 [44]	1	1	1	1	1	1	0	2	1	1	0	0	10
Vieira et al., 2018 [45]	1	1	0	1	0	2	0	2	0	1	1	1	10